Background Autoimmune diseases are a group of complex chronic illnesses that affect multiple organs or body systems. These diseases are characterized by tissue damage, impaired organ function, and increased risk of malignancies, and elevated mortality. Nevertheless, the casual correlation between autoimmune diseases and telomere length remains uncertain. Objective Our bidirectional Mendelian randomization analysis was aimed to evaluate the causal association between autoimmune diseases and telomere length. Methods To minimize bias, four demographic factors including body mass index (BMI), alcohol consumption, smoking, and income were assessed using two-sample Mendelian randomization analysis. Furthermore, this analysis was conducted to explore the causal relationships between telomere length and autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), type 1 diabetes (T1D), Graves’ disease (GD), and psoriasis using two separate datasets from FinnGen and the UK Biobank. Results When using inverse variance weighting (IVW) to assess the relationship between four available demographic factors and overall autoimmune diseases, no significant association was found (p > 0.05). However, a significant negative causal effect of telomere length on autoimmune diseases was observed (IVW: OR = 0.906, 95% CI = 0.832–0.986, p = 0.022). Reverse Mendelian randomization analysis revealed no significant correlation. Further analysis using two separate datasets for five common autoimmune diseases confirmed significant negative associations between telomere length and RA (UKB biobank: OR = 0.997, 95% CI 0.994–0.999, p = 0.025; FinnGen: OR = 0.860, 95% CI 0.741–0.998, p = 0.047), GD (UK Biobank: OR = 0.519, 95% CI 0.430–0.625, p < 0.001; FinnGen: OR = 0.623, 95% CI 0.496–0.785, p < 0.001), and psoriasis (UK Biobank: OR = 0.772, 95%CI = 0.642–0.928, p = 0.006; FinnGen: OR = 0.841, 95%CI = 0.727–0.973, p = 0.020). A significant positive association was found for SLE in the UK Biobank (OR = 1.718, 95% CI = 95% CI 1.155–2.558, p = 0.007). Reverse Mendelian randomization analysis identified a significant negative association between telomere length and SLE (UK Biobank: OR = 0.995, 95% CI 0.991–0.998, p = 0.014; FinnGen: OR = 0.988, 95% CI 0.977–0.998, p = 0.029) and psoriasis (FinnGen: OR = 0.992, 95% CI 0.988–0.997, P = 0.005), and a positive association with RA (UK Biobank: OR = 1.988 95% CI 1.056–3.743, p = 0.031). Conclusions This Mendelian randomization analysis reveals a significant association between telomere length and autoimmune diseases such as RA, GD, and psoriasis, while a positive relationship was validated with SLE. These findings underscore the need for further investigation to better understand the underlying mechanisms and their potential clinical applications.

Bidirectional Mendelian randomization reveals associations between telomere length and autoimmune diseases

期刊论文
出版模式：

开放获取
发表日期：

2025年4月23日

查看全文

Qin Jiang,
Chenxi Yu,
Shiben Zhu,
Yang Liu,
Min Ye

摘要

Background

Autoimmune diseases are a group of complex chronic illnesses that affect multiple organs or body systems. These diseases are characterized by tissue damage, impaired organ function, and increased risk of malignancies, and elevated mortality. Nevertheless, the casual correlation between autoimmune diseases and telomere length remains uncertain.

Objective

Our bidirectional Mendelian randomization analysis was aimed to evaluate the causal association between autoimmune diseases and telomere length.

Methods

To minimize bias, four demographic factors including body mass index (BMI), alcohol consumption, smoking, and income were assessed using two-sample Mendelian randomization analysis. Furthermore, this analysis was conducted to explore the causal relationships between telomere length and autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), type 1 diabetes (T1D), Graves’ disease (GD), and psoriasis using two separate datasets from FinnGen and the UK Biobank.

Results

When using inverse variance weighting (IVW) to assess the relationship between four available demographic factors and overall autoimmune diseases, no significant association was found (p > 0.05). However, a significant negative causal effect of telomere length on autoimmune diseases was observed (IVW: OR = 0.906, 95% CI = 0.832–0.986, p = 0.022). Reverse Mendelian randomization analysis revealed no significant correlation. Further analysis using two separate datasets for five common autoimmune diseases confirmed significant negative associations between telomere length and RA (UKB biobank: OR = 0.997, 95% CI 0.994–0.999, p = 0.025; FinnGen: OR = 0.860, 95% CI 0.741–0.998, p = 0.047), GD (UK Biobank: OR = 0.519, 95% CI 0.430–0.625, p < 0.001; FinnGen: OR = 0.623, 95% CI 0.496–0.785, p < 0.001), and psoriasis (UK Biobank: OR = 0.772, 95%CI = 0.642–0.928, p = 0.006; FinnGen: OR = 0.841, 95%CI = 0.727–0.973, p = 0.020). A significant positive association was found for SLE in the UK Biobank (OR = 1.718, 95% CI = 95% CI 1.155–2.558, p = 0.007). Reverse Mendelian randomization analysis identified a significant negative association between telomere length and SLE (UK Biobank: OR = 0.995, 95% CI 0.991–0.998, p = 0.014; FinnGen: OR = 0.988, 95% CI 0.977–0.998, p = 0.029) and psoriasis (FinnGen: OR = 0.992, 95% CI 0.988–0.997, P = 0.005), and a positive association with RA (UK Biobank: OR = 1.988 95% CI 1.056–3.743, p = 0.031).

Conclusions

This Mendelian randomization analysis reveals a significant association between telomere length and autoimmune diseases such as RA, GD, and psoriasis, while a positive relationship was validated with SLE. These findings underscore the need for further investigation to better understand the underlying mechanisms and their potential clinical applications.